Literature DB >> 21963800

The development of vaccines: how the past led to the future.

Stanley A Plotkin1, Susan L Plotkin.   

Abstract

The history of vaccine development has seen many accomplishments, but there are still many diseases that are difficult to target, and new technologies are being brought to bear on them. Past successes have been largely due to elicitation of protective antibodies based on predictions made from the study of animal models, natural infections and seroepidemiology. Those predictions have often been correct, as indicated by the decline of many infections for which vaccines have been made over the past 200 years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963800     DOI: 10.1038/nrmicro2668

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  47 in total

1.  Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine.

Authors:  S L KATZ; C H KEMPE; F L BLACK; M L LEPOW; S KRUGMAN; R J HAGGERTY; J F ENDERS
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

2.  Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus.

Authors:  H KOPROWSKI; G A JERVIS; T W NORTON
Journal:  Am J Hyg       Date:  1952-01

Review 3.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 4.  The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.

Authors:  H Fred Clark; Paul A Offit; Stanley A Plotkin; Penny M Heaton
Journal:  Pediatr Infect Dis J       Date:  2006-07       Impact factor: 2.129

5.  Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production.

Authors:  M D Cooper; W A Cain; P J Van Alten; R A Good
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

6.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

7.  An inactivated hepatitis A viral vaccine of cell culture origin.

Authors:  P J Provost; J V Hughes; W J Miller; P A Giesa; F S Banker; E A Emini
Journal:  J Med Virol       Date:  1986-05       Impact factor: 2.327

8.  Development and clinical trials of the new human rabies vaccine of tissue culture (human diploid cell) origin.

Authors:  T J Wiktor; S A Plotkin; H Koprowski
Journal:  Dev Biol Stand       Date:  1978

9.  Systems biology of vaccination for seasonal influenza in humans.

Authors:  Helder I Nakaya; Jens Wrammert; Eva K Lee; Luigi Racioppi; Stephanie Marie-Kunze; W Nicholas Haining; Anthony R Means; Sudhir P Kasturi; Nooruddin Khan; Gui-Mei Li; Megan McCausland; Vibhu Kanchan; Kenneth E Kokko; Shuzhao Li; Rivka Elbein; Aneesh K Mehta; Alan Aderem; Kanta Subbarao; Rafi Ahmed; Bali Pulendran
Journal:  Nat Immunol       Date:  2011-07-10       Impact factor: 25.606

10.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  84 in total

Review 1.  Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's Toolbox.

Authors:  David J Dowling; Ofer Levy
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

2.  Manipulating Memory CD8 T Cell Numbers by Timed Enhancement of IL-2 Signals.

Authors:  Marie T Kim; Samarchith P Kurup; Gabriel R Starbeck-Miller; John T Harty
Journal:  J Immunol       Date:  2016-07-20       Impact factor: 5.422

3.  Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity.

Authors:  Fan Zhang; Ying-Jie Lu; Richard Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

4.  Engineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.

Authors:  Anton Beletskii; Ashley Galloway; Shyam Rele; Michele Stone; Frank Malinoski
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 5.  mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

Authors:  Giulietta Maruggi; Cuiling Zhang; Junwei Li; Jeffrey B Ulmer; Dong Yu
Journal:  Mol Ther       Date:  2019-02-07       Impact factor: 11.454

6.  History of vaccination.

Authors:  Stanley Plotkin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

Review 7.  Vaccines, new opportunities for a new society.

Authors:  Rino Rappuoli; Mariagrazia Pizza; Giuseppe Del Giudice; Ennio De Gregorio
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

8.  Ixodes scapularis saliva components that elicit responses associated with acquired tick-resistance.

Authors:  Sukanya Narasimhan; Cheyne Kurokawa; Husrev Diktas; Norma Olivares Strank; Jiří Černý; Kristen Murfin; Yongguo Cao; Geoff Lynn; Jos Trentleman; Ming-Jie Wu; Kathy DePonte; Fred Kantor; Juan Anguita; Joppe Hovius; Erol Fikrig
Journal:  Ticks Tick Borne Dis       Date:  2020-01-03       Impact factor: 3.744

9.  Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.

Authors:  Jannick Prentoe; Rodrigo Velázquez-Moctezuma; Elias H Augestad; Andrea Galli; Richard Wang; Mansun Law; Harvey Alter; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-30       Impact factor: 11.205

10.  Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses.

Authors:  Gaetan Barbet; Leif E Sander; Matthew Geswell; Irina Leonardi; Andrea Cerutti; Iliyan Iliev; J Magarian Blander
Journal:  Immunity       Date:  2018-03-13       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.